Individual 6-year systolic blood pressure change and impact on cardiovascular mortality in a French general population

Pannier, Bruno; Thomas, Frédérique; Hanon, Olivier; Czernichow, Sébastien; Lemogne, Cédric; Simon, Tabassome; Jm, Simon; Danchin, Nicolás

doi:10.1038/jhh.2015.44

Cited by 6 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Data from the Minnesota Business and Professional Men Study (n=261) and the Zutphen Study were shown, and the 10-year BP trajectory was the strongest predictor of cardiovascular mortality and all-cause mortality in Minnesota [19]. Cardiovascular health studies concluded that long-term visit-to-visit SBP variability was independently associated with a higher risk of subsequent mortality and a meta-analysis of 13 cohort studies in Japan also presented that adjusted mortality increased with increasing BP [20, 21]. These studies found that BP changes are a powerful predictor of cardiovascular events independently of mean SBP or DBP, which is more common in previous studies.…”

Section: Discussionmentioning

confidence: 99%

Short-Term and Long-Term Blood Pressure Changes and the Risk of All-Cause and Cardiovascular Mortality

Dai

Wang

Xie

et al. 2019

BioMed Research International

View full text Add to dashboard Cite

Background. Few studies compared the effects of BP changes in short- and long-terms on all-cause mortality and CVD mortality. Methods. We performed a 12.5-year follow-up study to examine the association between short- (2008 to 2010) and long-term [baseline (2004-2006) to 2010] BP changes and the risk of mortality (2010 to 2017) in the Fuxin prospective cohort study. The Cox proportional hazards model was used for this study, and the average BP was stratified according to the Seven Joint National Committee (JNC7). Results. We identified 1496 (805 CVD deaths) and 2138 deaths (1222 CVD deaths) in short- and long-term study. Compared with BP maintainer, in short-term BP changes, for participants from normotension or prehypertension to hypertension, the hazards ratios (HRs) and 95% confidence intervals (CIs) of all-cause mortality were 1.948 (1.118-3.392) and 1.439 (1.218-1.700), respectively, while for participants from hypertension to prehypertension, the HRs (95% CIs) were 0.766 (0.638-0.899) for all-cause mortality and 0.729 (0.585-0.908) for CVD mortality, respectively. In long-term BP changes, for participants from normotension or prehypertension to hypertension, the HRs (95% CIs) of all-cause mortality were 1.738 (1.099-2.749) and 1.203 (1.023-1.414), and they were 2.351 (1.049-5.269) and 1.323 (1.047-1.672) for CVD mortality, respectively. In addition, the effects of short-term BP changes on all-cause and CVD mortality, measured as regression coefficients (β), were significantly greater than those in long-term change (all P<0.05). Conclusions. Our study emphasizes that short-term changes in BP have a greater impact on all-cause and CVD mortality than long-term changes and assess the cut-off value of the changes in blood pressure elevation.

show abstract

Section: Discussionmentioning

confidence: 99%

Short-Term and Long-Term Blood Pressure Changes and the Risk of All-Cause and Cardiovascular Mortality

Dai

Wang

Xie

et al. 2019

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Схожие результаты получены исследователями многих стран мира. Так, согласно данным 6-летнего исследования, проведенного во Франции, риск смерти от всех причин у лиц с повышенным САД в 1,31 раза выше, чем у лиц с нормальным АД, а от ССЗ -в 2,51 раза [8]. В Иранском когортном исследовании установлено, что вероятность смерти от всех причин и от ССЗ увеличивается пропорционально увеличению АД [9].…”

Section: Discussionunclassified

Impact of Arterial Hypertension on the Formation of the Risk of Mortality. Results of a 27‑Year Prospective Study

Ivanova

Долгалев

2018

CARDIO

View full text Add to dashboard Cite

А ртериальная гипертензия (АГ)-один из важнейших модифицируемых факторов риска (ФР) развития сердечно-сосудистых заболеваний (ССЗ), в первую очередь ишемической болезни сердца и цереброваскулярной болезни, на долю которых приходится около ⅓ (31 %) от общего числа смертей в мире [1]. Ежегодно от ССЗ умирают около 17 млн человек, причем около 9,4 млн из них-от осложнений АГ [2]. Около 45 % случаев смерти от болезней сердца и 51 %-от инсульта вызваны повышенным артериальным давлением (АД) [2]. В то же

show abstract

“…Наши результаты согласуются с данными многих крупных исследований, выявивших высокие показатели ОР среди курящих и у лиц, страдающих АГ [8,9]. Кроме того, многие исследователи сообщают о существовании тесной взаимосвязи между АГ и курением и о наличии экспоненциального усиления их отрицательного влияния на кардиоваскулярную систему при их сочетании [10].…”

Section: обсждениеunclassified

Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk)

et al. 2019

View full text Add to dashboard Cite

Aim. To study the influence of arterial hypertension (AH), smoking, and their combination on the risk of all cause and cardiovascular mortality.Material and methods. We conducted a 27-year cohort prospective study of the unorganized population of Tomsk (916 women and 630 men aged 20-59 years). At the first stage, we studied the prevalence of AH and smoking (1998-1991), at the second (2015) — the effect of these risk factors (RF) and their combination on the risk of all cause and cardiovascular mortality. AH was diagnosed at a blood pressure level of >140/90 mmHg and <140/90 mm Hg in individuals taking antihypertensive drugs. Smokers were individuals who smoked at least 1 cigarette per day and quit smoking less than one year ago.Results. The study found a significant effect of AH and smoking on mortality: the relative risk (RR) of all-cause mortality in people with hypertension was 2,2, in smokers — 2,3, in those with a combination of RF — 5,0. The RR of cardiovascular mortality in AH individuals was 3,4, in smokers — 1,6, in smoking men and women suffering from AH — 5,2. An increase in the risk of all-cause mortality in people with AH and smoking was observed in all gender-age groups. Smoking was found to increase the risk of all-cause mortality in individuals with high levels of blood pressure by 2,1 times compared with non-smoking hypertensive patients. It reduces the chances of a 27-year survival rate to 64,4%, and more so in the youngest (20-39 years) age group (RR — 3,9). Multivariate analysis showed that AH and smoking make the most significant contribution to the formation of mortality compared to other modifiable RFs.Conclusion. We found that AH and smoking are among the most influential RFs, and their combination increases the RR of all-cause mortality by 5,0 times (cardiovascular — 5,2 times). We also determined an additional risk of smoking in individuals suffering from AH to the all-cause mortality.

show abstract

Individual 6-year systolic blood pressure change and impact on cardiovascular mortality in a French general population

Cited by 6 publications

References 18 publications

Short-Term and Long-Term Blood Pressure Changes and the Risk of All-Cause and Cardiovascular Mortality

Short-Term and Long-Term Blood Pressure Changes and the Risk of All-Cause and Cardiovascular Mortality

Impact of Arterial Hypertension on the Formation of the Risk of Mortality. Results of a 27‑Year Prospective Study

Influence of arterial hypertension, smoking, and their combination on mortality (according to the results of a 27-year cohort prospective study of the unorganized population of Tomsk)

Contact Info

Product

Resources

About